REGISTERED COMPANY NUMBER: 01676618 (England and Wales)
REGISTERED CHARITY NUMBER: 286197
Report of the Trustees and
Unaudited Financial Statements for the Year Ended 31 December 2024
for
British Toxicology Society(The)
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
British Toxicology Society(The)
Contents of the Financial Statements for the Year Ended 31 December 2024
|
Page |
Report of the Trustees |
1 to 2 |
Independent Examiner's Report |
3 |
Statement of Financial Activities |
4 |
Balance Sheet |
5 to 6 |
Notes to the Financial Statements |
7 to 13 |
Detailed Statement of Financial Activities |
14 to 16 |
British Toxicology Society(The)
Report of the Trustees for the Year Ended 31 December 2024
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006,presenttheir report
withthefinancialstatementsofthecharityfortheyearended31December2024.Thetrusteeshaveadopted the
provisionsofAccountingandReportingbyCharities:StatementofRecommendedPracticeapplicableto charities
preparingtheiraccountsinaccordancewiththeFinancialReportingStandardapplicableintheUKandRepublic of
Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and significant activities
TheSocietyisestablishedforthepromotionandadvancement,forthepublicbenefit,ofeducationinthescience of
toxicology.In decidingthe aims and activitiesof the society,the trusteeshave paiddue regardto the guidance issued
by the CharityCommissionon publicbenefit.Toxicologyis the scienceof diseaseinducedby chemicalspresentin the
diet,medicines,andintheenvironment.TheBritishToxicologySociety(BTS)isaleadinginternational toxicology
society,basedonthehighestqualityscience,andpromotestheadvancement,communicationandunderstanding of
the scientific disciplines necessary to foster public health and environmental safety.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The Societyis a companylimitedby guaranteeandthe liabilityof members is limitedto an amountnot exceeding £1.
ItisexemptunderSection60oftheCompaniesAct2006fromtherequirementtousetheword'Limited'inits title.
TheSocietyisgovernedbytheMemorandumandArticlesofAssociation.Itisregisteredwiththe Charities
Commission, number 286197, and no liability to taxation arises.
TheExecutiveCommitteeareDirectorsforthepurposeofcompanylawandTrusteesforthepurposeofcharity law.
Directors/TrusteesareappointedbytheSociety'smembersattheAnnualGeneralMeeting.WhenaTrustee retires,
theExecutiveCommitteenominatesnewTrustees.Additionalnominationsmaybemadebythe membership,
provided they are signed by six members of the Society.
InformalinductionproceduresareinplacefornewTrustees,conductedbyanexistingmemberofthe Executive
Committeeandtheyarealsoprovidedwithrelevantdocumentationtoformallyadviseandinformthemof the
Society's constitution and objectives and also their duties and responsibilities as a trustee.
OnethirdoftheExecutiveCommitteeordinarymembersretireeachyearinrotationbutaretheneligible for
re-election.ThesocietyisorganisedsothattheTrustees,intheformoftheExecutiveCommittee,meet regularly,
usuallyonaquarterlybasis,tomanageitsaffairs.Therearealsosub-committeeswhichareresponsiblefor advising
and researching the various activities and development of the Society, who report to the Executive Committee.
Statutesfor the workingsof the varioussub-committeesare continuallybeingrevisedand updatedto ensurethat the
termsofreferenceareclearlydefinedandthewaysofworkingareconsistent.Thisalsoenablestransparency of
committeeelectionsanddurationof membership,whileallowingthecommitteesto worktoagreedaims,backed up
by comprehensive set of Standard Operating Procedures for the Society.
ThetrusteeshaveassessedthemajorriskstowhichtheSocietyisexposed,inparticularthoserelatedto the
operations and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks.
All of the officers and members who serve on the Society'scommitteesare unpaid.They are entitledto be reimbursed
for any out of pocket expenses incurred in attending meetings.
Norelatedparties,relatedpartytransactions,beneficialrelationshipsorconflictsofinterestrequiringdisclosure by
the Charities' or Companies' Acts existed during the year.
AttendancebyExecutiveCommitteemembershasbeenreasonablethroughouttheyear.Theco-opted members
continue to provide liaison with the relevant Sub-Committees and Speciality Sections.
The day to day administration of the Society is undertaken by an outside agency on a fee basis.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
01676618 (England and Wales)
Registered Charity number
286197
Page 1
British Toxicology Society(The)
Report of the Trustees for the Year Ended 31 December 2024
Registered office
Executive Business Support Limited
Stowe House
St Chad's Road
Lichfield
Staffordshire
WS13 6TJ
Trustees
Professor B G Lake Toxicologist (resigned 15/4/2024)
Dr E Marczylo Toxicologist (resigned 15/4/2024)
Dr D R Mason Toxicological Safety (resigned 15/4/2024)
Professor S C Price Professor Of Toxicology
Dr F Sewell Programme Manager
Dr P A Botham Toxicologist
Dr L M Reeve Toxicologist (resigned 15/4/2024)
Dr I Copple Senior Lecturer in Pharmacology
Dr B Ross Senior Consultant Toxicologist
Dr H Matar Associate Professor of Toxicology
Mrs F Hill Civil servant
Dr E Idahosa-Taylor Toxicologist
Prof V Stone Director (appointed 15/4/2024)
Prof T Gant Head of Toxicology (appointed 15/4/2024)
R Ghosh Principal Toxicologist (appointed 15/4/2024)
Company Secretary
Professor S C Price
Independent Examiner
Jonathon Dickens ACA
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
Approved by order of the board of trustees on ............................................. and signed on its behalf by:
........................................................................
Mrs F Hill - Trustee
Page 2
Independent Examiner's Report to the Trustees of British Toxicology Society(The)
Independent examiner's report to the trustees of British Toxicology Society(The) ('the Company')
IreporttothecharitytrusteesonmyexaminationoftheaccountsoftheCompanyfortheyear ended
31 December 2024.
Responsibilities and basis of report
As the charity'strusteesof the Company(andalsoits directorsfor the purposesof companylaw)youare responsible
for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
HavingsatisfiedmyselfthattheaccountsoftheCompanyarenotrequiredtobeauditedunderPart16ofthe 2006
Actandareeligibleforindependentexamination,I reportinrespectof my examinationof yourcharity'saccounts as
carriedoutunderSection145oftheCharitiesAct2011('the2011Act').IncarryingoutmyexaminationI have
followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.
Independent examiner's statement
Since yourcharity'sgross incomeexceeded£250,000yourexaminermust be a member of a listedbody.I can confirm
thatIamqualifiedtoundertaketheexaminationbecauseIamamemberoftheAssociationofChartered Certified
Accountants, which is one of the listed bodies.
Ihavecompletedmyexamination.Iconfirmthatnomattershavecometomyattentioninconnectionwith the
examination giving me cause to believe:
1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationtowhich attention
should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Jonathon Dickens ACA
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
7 May 2025
Page 3
British Toxicology Society(The)
Statement of Financial Activities
for the Year Ended 31 December 2024
Unrestricted
fund
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
84,966
Charitable activities
Annual Congress
147,675
Annual Congress trade exhibition
3,360
PATDD, ACT joint meetings, webinars and online
events
10,622
Other trading activities
2
9,375
Investment income
3
12,549
Total
268,547
EXPENDITURE ON
Raising funds
4
25,430
Charitable activities
5
Annual Congress
156,817
Annual Congress trade exhibition
-
PATDD, ACT joint meetings, webinars and online
events
592
Donations and subscriptions to other societies
7,968
Travel bursaries and early career support
4,792
Other
62,867
Total
258,466
NET INCOME
10,081
RECONCILIATION OF FUNDS
Total funds brought forward
383,625
TOTAL FUNDS CARRIED FORWARD
393,706 |
Restricted
funds
£
5,000
-
-
-
-
285
5,285
-
-
-
-
-
75
-
75
5,210
10,104
15,314 |
2024
Total
funds
£
89,966
147,675
3,360
10,622
9,375
12,834
273,832
25,430
156,817
-
592
7,968
4,867
62,867
258,541
15,291
393,729
409,020 |
2023
Total
funds
£
73,364
122,191
3,970
10,790
11,487
7,468 |
|
|
|
229,270 |
|
|
|
22,404
137,856
107
-
7,232
7,701
43,669 |
|
|
|
218,969 |
|
|
|
10,301
383,428 |
|
|
|
393,729 |
The notes form part of these financial statements
Page 4
British Toxicology Society(The)
Balance Sheet
31 December 2024
Unrestricted
fund
Notes
£
CURRENT ASSETS
Debtors
9
74,282
Cash at bank
342,841
417,123
CREDITORS
Amounts falling due within one year
10
(23,417)
NET CURRENT ASSETS
393,706
TOTAL ASSETS LESS CURRENT LIABILITIES
393,706
NET ASSETS
393,706
FUNDS
11
Unrestricted funds
Restricted funds
TOTAL FUNDS |
Restricted
funds
£
-
15,314
15,314
-
15,314
15,314
15,314 |
2024
Total
funds
£
74,282
358,155
432,437
(23,417)
409,020
409,020
409,020
393,706
15,314
409,020 |
2023
Total
funds
£
65,125
397,599
462,724
(68,995)
393,729
393,729
393,729
383,625
10,104
393,729 |
|
|
|
|
The charitablecompanyis entitledto exemptionfrom audit under Section477 of the CompaniesAct 2006 for the year
ended 31 December 2024.
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsfortheyear ended
31 December 2024 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
The notes form part of these financial statements
continued...
Page 5
British Toxicology Society(The)
Balance Sheet - continued
31 December 2024
Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicabletocharitable companies
subject to the small companies regime.
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
............................................. and were signed on its behalf by:
.............................................
F Hill - Trustee
.............................................
S C Price - Trustee
The notes form part of these financial statements
Page 6
British Toxicology Society(The)
Notes to the Financial Statements
for the Year Ended 31 December 2024
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financialstatementsof the charitablecompany,whichis a publicbenefitentityunderFRS 102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingbyCharities: Statement
ofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial
ReportingStandardapplicablein the UK and Republicof Ireland(FRS 102) (effective1 January2019)', Financial
ReportingStandard102 'The FinancialReportingStandardapplicablein the UK and Republicof Ireland'and the
Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Going concern
There are no material uncertainties about the charity's ability to continue.
Thetrustees'assessmentoftherisksassociatedwithBrexitandthepandemicaredetailedinthe President's
report.
Financial reporting standard 102 - reduced disclosure exemptions
Thecharitablecompanyhastakenadvantageofthefollowingdisclosureexemptionsinpreparing these
financialstatements,aspermittedbyFRS102'TheFinancialReportingStandardapplicableintheUK and
Republic of Ireland':
-
the requirements of Section 7 Statement of Cash Flows;
-
the requirement of paragraph 3.17(d);
-
the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
-
the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;
-
the requirement of paragraph 33.7.
Income
All incomingresourcesare includedin the statementof financialactivitieswhen entitlementhas passedto the
charity;itisprobablethattheeconomicbenefitsassociatedwiththetransactionwillflowtothecharity and
theamountcanbereliablymeasured.Thefollowingspecificpoliciesareappliedtoparticularcategories of
income:
-Incomefromdonationsorgrantsisrecognisedwhenthereisevidenceofentitlementtothegift,receipt is
probable and its amount can be measured reliably.
- Legacy income is recognised when receipt is probable and entitlement is established.
- Incomefromdonatedgoodsismeasuredatthefairvalueofthegoodsunlessthisisimpracticalto measure
reliably,inwhichcasethevalueisderivedfromthecosttothedonorortheestimatedresalevalue. Donated
facilitiesandservicesarerecognisedintheaccountswhenreceivedifthevaluecanbereliablymeasured. No
amounts are included for the contribution of general volunteers.
- Income from contractsfor the supplyof services is recognisedwith the delivery of the contractedservice. This
isclassifiedasunrestrictedfundsunlessthereisacontractualrequirementforittobespentona particular
purpose and returned if unspent, in which case it may be regarded as restricted.
Expenditure
Expenditureisrecognisedonanaccrualsbasisasaliabilityisincurred.ExpenditureincludesanyVAT which
cannotbefullyrecovered,andisclassifiedunderheadingsofthestatementoffinancialactivitiestowhich it
relates:
-Expenditureonraisingfundsincludesthecostsofallfundraisingactivities,events,non-charitable trading
activities, and the sale of donated goods.
continued...
Page 7
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2024
1. ACCOUNTING POLICIES - continued
Expenditure
-Expenditureoncharitableactivitiesincludesallcostsincurredbyacharityinundertakingactivities that
furtherits charitableaims for the benefit of its beneficiaries,includingthose supportcosts and costs relating to
the governance of the charity apportioned to charitable activities.
- Otherexpenditureincludesallexpenditurethatis neitherrelatedtoraisingfundsforthecharitynorpart of
its expenditure on charitable activities.
All costsare allocatedto expenditurecategoriesreflectingthe use of the resource.Directcostsattributable to
a singleactivityare allocateddirectlyto that activity.Sharedcosts are apportionedbetweenthe activities they
contribute to on a reasonable, justifiable and consistent basis.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsofthe charity.
Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial
statements.
2. OTHER TRADING ACTIVITIES
OTHER TRADING ACTIVITIES |
|
|
Unrestricted
Restricted
funds
funds
£
£
Website advertising
7,875
-
OUP / RSC Journal income
1,500
-
9,375
- |
2024
Total
funds
£
7,875
1,500
9,375 |
2023
Total
funds
£
9,667
1,820 |
|
|
11,487 |
3. INVESTMENT INCOME
INVESTMENT INCOME |
|
|
|
|
|
|
|
2024 |
2023 |
|
Unrestricted |
Restricted |
Total |
Total |
|
funds |
funds |
funds |
funds |
|
£ |
£ |
£ |
£ |
Deposit account interest |
12,549 |
285 |
12,834 |
7,468 |
continued...
Page 8
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2024
4. RAISING FUNDS
Raising donations and legacies
Raising donations and legacies |
|
|
|
|
Unrestricted
funds
£
Bank charges
1,972
EBS - membership processing
12,226
Support costs
8,084
22,282
Other trading activities
Unrestricted
funds
£
ACT webinars
-
Bank charges
43
Speciality section meetings
1,100
Joint BPS-BTS meeting
2,005
Support costs
-
3,148
Aggregate amounts
25,430
5.
CHARITABLE ACTIVITIES COSTS
Annual Congress
PATDD, ACT joint meetings, webinars
and online events
Donations and subscriptions to other
societies
Travel bursaries and early career
support |
Restricted
funds
£
-
-
-
-
Restricted
funds
£
-
-
-
-
-
-
-
Direct
Costs
£
124,172
592
6,121
4,867
135,752 |
2024
Total
funds
£
1,972
12,226
8,084
22,282
2024
Total
funds
£
-
43
1,100
2,005
-
3,148
25,430
Support
costs (see
note 6)
£
32,645
-
1,847
-
34,492 |
2023
Total
funds
£
1,151
11,677
7,721
20,549
2023
Total
funds
£
1,015
90
-
-
750
1,855
22,404
Totals
£
156,817
592
7,968
4,867 |
2023
Total
funds
£
1,151
11,677
7,721 |
|
|
|
|
20,549 |
|
|
|
|
2023
Total
funds
£
1,015
90
-
-
750
1,855
22,404 |
|
|
|
170,244 |
|
continued...
Page 9
British Toxicology Society(The)
Notes to the Financial Statements - continued for the Year Ended 31 December 2024
6. SUPPORT COSTS
Management
£
Raising donations and
legacies
-
Other resources expended
9,046
Annual Congress
145
Donations and
subscriptions to other
societies
-
9,191 |
Information
Governance
Finance
technology
costs
£
£
£
8,084
-
-
6,739
39,417
7,665
-
-
32,500
1,347
500
-
16,170
39,917
40,165 |
Totals
£
8,084
62,867
32,645
1,847 |
|
|
105,443 |
7. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees'remunerationor other benefitsfor the year ended 31 December 2024 nor for the year
ended 31 December 2023.
Trustees' expenses
Trustees' expenses |
|
|
|
Trustees' expenses
8.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
73,364
Charitable activities
Annual Congress
122,191
Annual Congress trade exhibition
3,970
PATDD, ACT joint meetings, webinars and
online events
10,790
Other trading activities
11,487
Investment income
7,378
Total
229,180
EXPENDITURE ON
Raising funds
22,404
Charitable activities
Annual Congress
137,856
Annual Congress trade exhibition
107
Donations and subscriptions to other
societies
7,232
Travel bursaries and early career support
7,701
Other
43,669 |
2024
£
1,068
Restricted
funds
£
-
-
-
-
-
90
90
-
-
-
-
-
- |
2023
£
187
Total
funds
£
73,364
122,191
3,970
10,790
11,487
7,468 |
|
|
|
|
229,270 |
|
|
|
22,404
137,856
107
7,232
7,701
43,669 |
continued...
Page 10
British Toxicology Society(The)
Notes to the Financial Statements - continued for the Year Ended 31 December 2024
8.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
fund
£
Total
218,969
NET INCOME
10,211
RECONCILIATION OF FUNDS
Total funds brought forward
373,414
TOTAL FUNDS CARRIED FORWARD
383,625
9.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Debtors
Prepayments & accrued income
10.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade creditors
Accruals & prepaid income
11.
MOVEMENT IN FUNDS
At 1/1/24
£
Unrestricted funds
General fund
383,625
Restricted funds
Barnes fund
814
Paton fund
3,812
Norman Aldridge fund
5,478
10,104
TOTAL FUNDS
393,729 |
Restricted
funds
£
-
90
10,014
10,104
2024
£
11,140
63,142
74,282
2024
£
5,521
17,896
23,417
Net
movement
in funds
£
10,081
22
107
5,081
5,210
15,291 |
Total
funds
£
218,969
10,301
383,428
393,729
2023
£
6,073
59,052
65,125
2023
£
52,680
16,315
68,995
At
31/12/24
£
393,706
836
3,919
10,559
15,314
409,020 |
Total
funds
£ |
|
|
|
218,969 |
|
|
|
10,301
383,428 |
|
|
|
393,729 |
continued...
Page 11
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2024
11. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
Restricted funds
Barnes fund
Paton fund
Norman Aldridge fund
TOTAL FUNDS |
Incoming
resources
£
268,547
22
107
5,156
5,285
273,832 |
Resources
Movement
expended
in funds
£
£
(258,466)
10,081
-
22
-
107
(75)
5,081
(75)
5,210
(258,541)
15,291 |
|
|
|
Comparatives for movement in funds
Unrestricted funds
General fund
Restricted funds
Barnes fund
Paton fund
Norman Aldridge fund
TOTAL FUNDS |
At 1/1/23
£
373,414
813
3,777
5,424
10,014
383,428 |
Net
movement
in funds
£
10,211
1
35
54
90
10,301 |
At
31/12/23
£
383,625
814
3,812
5,478 |
|
|
|
10,104 |
|
|
|
393,729 |
continued...
Page 12
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2024
11. MOVEMENT IN FUNDS - continued
Comparative net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
Restricted funds
Barnes fund
Paton fund
Norman Aldridge fund
TOTAL FUNDS |
Incoming
resources
£
229,180
1
35
54
90
229,270 |
Resources
Movement
expended
in funds
£
£
(218,969)
10,211
-
1
-
35
-
54
-
90
(218,969)
10,301 |
|
|
|
Restrictedfundscomprisedonationsgiven to providelectureawards,travelgrantsand supportto early career
toxicologists. Awards are made by the trustees on an alternate year basis.
12. RELATED PARTY DISCLOSURES
There were no related party transactions.
Page 13
British Toxicology Society(The)
Detailed Statement of Financial Activities for the Year Ended 31 December 2024
Unrestricted
Restricted
funds
funds
£
£
INCOME AND ENDOWMENTS
Donations and legacies
Donations
21,977
5,000
Subscriptions
62,989
-
84,966
5,000
Other trading activities
Website advertising
7,875
-
OUP / RSC Journal income
1,500
-
9,375
-
Investment income
Deposit account interest
12,549
285
Charitable activities
Annual Congress delegates
107,975
-
Annual Congress donations
4,450
-
Annual Congress exhibitors and trade stands
3,360
-
PATDD & ACT joint meetings & webinars
10,622
-
BTS skills gap registration
29,400
-
Discovery Toxicology sponsorship
5,850
-
161,657
-
Total incoming resources
268,547
5,285
EXPENDITURE
Raising donations and legacies
Bank charges
1,972
-
EBS - membership processing
12,226
-
14,198
-
Other trading activities
ACT webinars
-
-
Bank charges
43
-
Speciality section meetings
1,100
-
Joint BPS-BTS meeting
2,005
-
3,148
- |
2024
Total
funds
£
26,977
62,989
89,966
7,875
1,500
9,375
12,834
107,975
4,450
3,360
10,622
29,400
5,850
161,657
273,832
1,972
12,226
14,198
-
43
1,100
2,005
3,148 |
2023
Total
funds
£
13,000
60,364 |
|
|
73,364
9,667
1,820 |
|
|
11,487
7,468
117,881
5,100
3,970
10,000
-
- |
|
|
136,951 |
|
|
229,270
1,151
11,677 |
|
|
12,828
1,015
90
-
- |
|
|
1,105 |
This page does not form part of the statutory financial statements
Page 14
British Toxicology Society(The)
Detailed Statement of Financial Activities for the Year Ended 31 December 2024
Unrestricted
Restricted
funds
funds
£
£
Other trading activities
Charitable activities
Insurance
1,183
-
Entertainment
1,650
-
Security
1,122
-
Speakers' expenses
4,615
-
Delegate materials
228
-
Accommodation and meals
96,058
-
Technicians and equipment hire
7,021
-
Bank charges
652
75
EBS management fee
8,089
-
EBS travel expenses
294
-
EBS processing fees
2,763
-
Eurotox subscription
1,702
-
Understanding Animal Research
665
-
Society of Biology
760
-
Iutox International
2,828
-
Early career prizes
664
-
Travel bursary
3,232
-
Studentship
1,500
-
Oral presentation prize
200
-
Recognition awards
9
-
Poster presentation prize
400
-
NEST promotional materials
42
-
135,677
75
Support costs
Management
Postage and stationery
507
-
EBS- trustee support
8,684
-
9,191
-
Finance
EBS- bookkeeping & finance
16,170
-
Information technology
EBS - website management
36,689
-
EBS- licences & IT support
2,728
-
EDIS membership contribution
500
-
39,917
-
Other
Provision for doubtful debt
-
- |
2024
Total
funds
£
1,183
1,650
1,122
4,615
228
96,058
7,021
727
8,089
294
2,763
1,702
665
760
2,828
664
3,232
1,500
200
9
400
42
135,752
507
8,684
9,191
16,170
36,689
2,728
500
39,917
- |
2023
Total
funds
£
1,338
1,841
-
3,748
991
93,086
15,017
288
17,892
192
3,179
1,910
291
660
3,032
-
6,587
-
300
653
100
461 |
|
|
151,566
214
8,293 |
|
|
8,507
15,443
20,059
2,686
- |
|
|
22,745
750 |
This page does not form part of the statutory financial statements
Page 15
British Toxicology Society(The)
Detailed Statement of Financial Activities for the Year Ended 31 December 2024
Detailed Statement of Financial Activities
for the Year Ended 31 December 2024 |
|
|
Unrestricted
Restricted
funds
funds
£
£
Other
Governance costs
Meeting expenses - trustees
1,068
-
Accountancy fees
6,478
-
Meeting expenses- non trustees
119
-
Project co-ordinator
32,500
-
40,165
-
Total resources expended
258,466
75
Net income
10,081
5,210 |
2024
Total
funds
£
1,068
6,478
119
32,500
40,165
258,541
15,291 |
2023
Total
funds
£
187
5,415
423
- |
|
|
6,025 |
|
|
218,969 |
|
|
10,301 |
This page does not form part of the statutory financial statements
Page 16